These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30905354)

  • 41. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
    Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
    Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study.
    Rosmolen WD; Nieuwkerk PT; Pouw RE; van Berge Henegouwen MI; Bergman JJ; Sprangers MA
    Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 27766707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
    Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
    Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Distribution of esophageal squamous cell cancer and precursor lesions in high-risk areas, Linzhou in Henan province and Feicheng in Shandong province of China, 2005-2009].
    Wang M; Hao C; Zhao D; Li B; Wang J; Lei F; Zhou R; Ma S; Ma Q; Li Y; Feng H; Li X; Wei W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):677-82. PubMed ID: 26733024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.
    Vliebergh JH; Deprez PH; de Looze D; Ferrante M; Orlent H; Macken E; Christiaens P; Mana F; De Hertogh G; Willekens H; Bisschops R
    Endoscopy; 2019 Apr; 51(4):317-325. PubMed ID: 30360011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic mucosal resection of early esophageal carcinoma--experience of 9 cases.
    Lin LF; Huang PT; Ho KS; Tung JN
    J Chin Med Assoc; 2008 Jul; 71(7):347-52. PubMed ID: 18653397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.
    McCaul JA; Cymerman JA; Hislop S; McConkey C; McMahon J; Mehanna H; Shaw R; Sutton DN; Dunn J
    Trials; 2013 Sep; 14():310. PubMed ID: 24063578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia.
    Kohoutova D; Haidry R; Banks M; Bown S; Sehgal V; Butt MA; Graham D; Thorpe S; Novelli M; Rodriguez-Justo M; Lovat L
    Scand J Gastroenterol; 2015; 50(11):1315-21. PubMed ID: 25956748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; ten Kate FJ; Visser M; Seldenrijk CA; van Berge Henegouwen MI; Weusten BL; Bergman JJ
    Endoscopy; 2011 Apr; 43(4):282-90. PubMed ID: 21455869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
    Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
    Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution.
    Sugimachi K; Kitamura K; Baba K; Ikebe M; Kuwano H
    Gastrointest Endosc; 1992; 38(6):657-61. PubMed ID: 1282113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endoscopic treatment of early esophageal squamous neoplasia.
    Fleischmann C; Messmann H
    Minerva Chir; 2018 Aug; 73(4):378-384. PubMed ID: 29843499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lugol's solution in endoscopic diagnosis of early esophageal cancer].
    Wang G; Zhou M; Cong Q
    Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):417-8, 446. PubMed ID: 7553162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of Lugol's iodine staining in the treatment of stage I-II squamous cell carcinoma of the tongue.
    Umeda M; Shigeta T; Takahashi H; Minamikawa T; Komatsubara H; Oguni A; Shibuya Y; Komori T
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):593-6. PubMed ID: 21334851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases.
    Nakanishi Y; Ochiai A; Yoshimura K; Kato H; Shimoda T; Yamaguchi H; Tachimori Y; Watanabe H; Hirohashi S
    Cancer; 1998 Apr; 82(8):1454-9. PubMed ID: 9554520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
    Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
    Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical relevance of the utilization of vital Lugol's iodine staining in detection and diagnosis of oral cancer and dysplasia.
    Elimairi I; Altay MA; Abdoun O; Elimairi A; Tozoglu S; Baur DA; Quereshy F
    Clin Oral Investig; 2017 Mar; 21(2):589-595. PubMed ID: 27491775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study.
    Mwachiro MM; Burgert SL; Lando J; Chepkwony R; Bett C; Bosire C; Abnet CC; Githanga J; Waweru W; Giffen CA; Murphy G; White RE; Topazian MD; Dawsey SM
    Am J Gastroenterol; 2016 Apr; 111(4):500-7. PubMed ID: 26902228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Telomerase activity in esophageal carcinoma and lesions unstained with Lugol's solution].
    Yoneyama K; Aoyama N; Koizumi H; Tamai S
    Nihon Rinsho; 1998 May; 56(5):1181-5. PubMed ID: 9613118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.